Continuing Education

Continuing Education Information


© 2018 Harborside™


  


ARTICLE

Understanding the Role of Targets and Pathways in the Treatment Melanoma

A continuing education activity for nurse practitioners, PAs, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.

Release date: November 27, 2018

Expiration date: November 27, 2019

Estimated time to complete activity: 3.0 hours

Certified for CE by:

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Drive, Dinah Shore Bldg.
Rancho Mirage, CA 92270
Voice: 760-773-4500
Fax: 760-773-4513
E-mail: contactce@annenberg.net

Journal of the Advanced Practitioner in Oncology
94 North Woodhull Road
Huntington, NY 11743
Voice: 631-692-0800
Fax: 631-692-0805
E-mail: editor@advancedpractitioner.com

© 2018, Annenberg Center for Health Sciences at Eisenhower. All rights reserved.

This activity is supported by educational grants from Array BioPharma, Inc. and Merck Sharp & Dohme Corp.

Faculty

Christan G. Bartsch, MSHS, PA-C, MPH, University of Colorado, Anschutz Medical Campus

Brianna Hoffner, MSN, ANP-BC, AOCNP®, University of Colorado Cancer Center

Lisa A. Kottschade, APRN, MSN, CNP, Mayo Clinic

Kathleen M. Madden, RN, MSN, FNP-BC, AOCNP®, APHN, Laura and Isaac Perlmutter Clinical Cancer Center at NYU Langone Medical Center

Suzanne McGettigan, MSN, CRNP, AOCN®, Abramson Cancer Center, University of Pennsylvania Health System

LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP, University of South Carolina

Mollie Reed, MSN, ACNP-BC, Tennessee Oncology

Krista M. Rubin, MS, FNP-BC, Massachusetts General Hospital Cancer Center

Intended Audience

The activity’s target audience will consist of nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists, and physicians.

Harborside Medical Education

Harborside Medical Education (HSME), a division of Harborside, is committed to advancing care for people with cancer and improving patient outcomes through professional continuing education (CE) activities in oncology that address practice gaps and promote change in learners’ knowledge, competence and performance in both community and academic practice settings.

Learning Objectives

After completing this educational activity, participants should be able to:

Discuss mechanisms of action, new indications and clinical data supporting emerging targeted therapies and immunotherapies used in the treatment of advanced/metastatic melanoma, including the impact these unique agents have on patient outcomes

Apply new skill sets to guide and manage treatment expectations of patients and their families

Formulate strategies to manage and mitigate potential adverse events from targeted therapies and immunotherapies used in the treatment of advanced/metastatic melanoma

Discuss the pivotal role and necessary expertise of the advanced practitioner as a leader and key contributor of the collaborative oncology healthcare team treating melanoma.

Continuing Education

Statement of Credit—Participants who successfully complete this activity (including the submission of the post-test and evaluation form) will receive a statement of credit.

ACCME Grayscale

Physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower, the Advanced Practitioner Society for Hematology and Oncology, and the Journal of the Advanced Practitioner in Oncology. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Nurses. The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider
of continuing nursing education by the American Nurses Credentialing Center’s Commission
on Accreditation.

A maximum of 3.0 contact hours may be earned for successful completion of this activity.

Provider approved by the California Board of Registered Nursing, Provider No. 13664, for 3.0 contact hours.

CE Pharmacists Logo

Pharmacists. This is a knowledge-based activity.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-18-223-H01-P. This program is designated for up to 3.0 contact hours (0.30 CEUs) of continuing pharmacy education credit.

Financial Disclosures

All individuals in positions to control the content of this program (e.g., planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Annenberg Center for Health Sciences at Eisenhower has identified and resolved all conflicts of interest in accordance with the ACHS policies and procedures. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity.

Disclosures

Faculty

Christan G. Bartsch, MSHS, PA-C, MPH, has nothing to disclose.

Brianna Hoffner, MSN, ANP-BC, AOCNP®, has served on the advisory board for Array BioPharma, Eli Lilly, and Merck.

Lisa A. Kottschade, APRN, MSN, CNP, has served as a consultant to Array BioPharma and Bristol-Myers Squibb, and has received research support from Bristol-Myers Squibb and Novartis.

Kathleen M. Madden, RN, MSN, FNP-BC, AOCNP®, APHN, has nothing to disclose.

Suzanne McGettigan, MSN, CRNP, AOCN®, has served on speakers bureaus for Bristol-Myers Squibb, Genentech, Merck, and Novartis.

LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP, has nothing to disclose.

Mollie Reed, MSN, ACNP-BC, has served as a consultant for Array Pharmaceuticals, Bristol-Myers Squibb, and Merck, and on the speakers bureaus for Bristol-Myers Squibb, Genentech, Merck, Novartis, and Taiho Oncology.

Krista M. Rubin, MS, FNP-BC, has served as a consultant for Bristol-Myers Squibb, EMD Serono, and Merck Sharp & Dohme Corp.

ANNENBERG CENTER FOR HEALTH SCIENCES AT EISENHOWER

Charles Willis, Director, Continuing Education, consults for Pfizer Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Lead Nurse Planner

Dorothy Caputo, MA, BSN, RN, EduPro Resources, LLC, has nothing to disclose.

Planners

Harborside and Harborside Medical Education staff have no potential conflicts of interest to disclose.

Content Reviewers

Monique Johnson, MD, CHCP, has nothing to disclose.

Pamela Hallquist Viale, RN, MS, CNS, ANP, has nothing to disclose.

Disclaimer

This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities, clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Annenberg Center for Health Sciences at Eisenhower educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.

The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by Annenberg Center for Health Sciences at Eisenhower of any specific therapeutics or approaches to diagnosis or patient management.

Product Disclosure

This educational activity may contain discussion of published as well as investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product.

How to Earn Credit

To access the learning assessment and evaluation form online, visit https://education.annenberg.net/PTP-melanoma

Statement of Credit: Participants who successfully complete this activity (including scoring of a minimum of 70% on the learning assessment) and complete and submit the evaluation form will be able to download a statement of credit.

Save


Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.